Patent intelligence · US
US 6610295
Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor
Patent details — US 6610295
- Jurisdiction
- US
- Status
- expired
- Grant date
- Aug 26, 2003
- Expiration
- Aug 21, 2023
- Applicant
- Cogent Partners, LP
- Claims
- 7
- CPC classes
- A61K, A61K39/00
Quick answer
US 6610295 (Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor) is held by Cogent Partners, LP. Status: expired. Granted Aug 26, 2003. Expires Aug 21, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Cogent Partners, LP
- Grant date
- Expiration
- Claims
- 7
- CPC classes
- A61K, A61K39/00
More from Cogent Partners, LP
Related pharmaceutical patents in our USPTO index.
-
US 12351581
Compounds for FGFR inhibition
granted -
US 12281122
PI3K inhibitors
granted -
US 11718576
Compositions and methods comprising resveratrol
granted -
US 11339112
Compositions and methods comprising resveratrol
granted -
US 10836702
Compositions and methods comprising resveratrol
granted -
US 10449129
Encapsulates of salicylic acid and polysalicylic acid derivatives
granted -
US 10301248
Compositions and methods comprising resveratrol
granted
Frequently asked questions
What is US patent 6610295?
US 6610295 (Processes for the production of HCMV glycoproteins, antibodies thereto and HCMV vaccines, and recombinant vectors therefor) is held by Cogent Partners, LP. Status: expired. Granted Aug 26, 2003. Expires Aug 21, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6610295?
Cogent Partners, LP is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 10 pharmaceutical patents for this assignee.
When does US 6610295 expire?
Our index shows an expiration date of Aug 21, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.